Mohideen Pharis reported DBVT

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001760395-25-000003

Machine-readable

Structured copy

Timestamps

Event (reported)

Nov 21, 2025

Published

Nov 25, 2025

Ingested by INSIDER

Nov 5, 04:31 UTC

Last re-read

Nov 5, 04:31 UTC

Extracted facts

Filer

Mohideen Pharis

Role

Chief Medical Officer

Transaction

Grant or awardAs filed: “A”

Asset

DBV Technologies S.A. — Employee Stock Option (right to buy)

Ticker

DBVT

Shares

253.0K

Price per share

$0

Execution date (reported)

Nov 21, 2025

Owned after transaction

253.0K shares

Days from execution to publication

4

What this establishes

Mohideen Pharis filed this Form 4 reporting a grant or award of DBVT on Nov 21, 2025. It became public on Nov 25, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Chief Medical Officer

Mohideen Phariscik:0001760395

Issuer

DBV Technologies S.A.cik:0001613780

Revision history · 0

No field has changed since this record was first ingested.